NASDAQ · Analyst Forecast

Xenon Pharmaceuticals Inc. (XENE) Stock Forecast & Price Target

$37.75 NASDAQ: XENE Market Cap $3.71B

Price as of Nov 18, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Xenon Pharmaceuticals Inc. (XENE), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Xenon Pharmaceuticals Inc., analysts forecast revenue rising from $7.58M in 2025 to $1.01B in 2030; the average estimate for 2030 earnings per share is $3.07; with published estimates ranging from $1.29 to $5.40; 14 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$37.75
Consensus targetThe average of the price targets analysts have published.$68.63
Median targetThe middle target, less affected by a single outlier.$67.00
Highest targetThe most optimistic published target.$90.00
Lowest targetThe most pessimistic published target.$46.00
Difference from priceHow far the consensus target sits from today’s price.+81.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$7.41M$7.58M$8.67M14
2026$796,114$1.44M$2.28M8
2027$24.88M$27.82M$30.74M12
2028$96.28M$211.49M$363.79M10
2029$351.79M$634.85M$1.01B5
2030$558.27M$1.01B$1.60B5

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$4.35−$4.25−$4.0614
2026−$4.83−$4.56−$4.288
2027−$5.25−$4.61−$3.6812
2028−$4.73−$3.40−$1.9710
2029$0.05$0.11$0.195
2030$1.29$3.07$5.405

Xenon Pharmaceuticals Inc. (XENE) forecast — frequently asked questions

What is the analyst price target for Xenon Pharmaceuticals Inc.?

Analysts covering Xenon Pharmaceuticals Inc. (XENE) have a consensus price target of $68.63, 81.8% above the current price of $37.75. Published targets range from $46.00 to $90.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Xenon Pharmaceuticals Inc.'s earnings?

The average analyst estimate for Xenon Pharmaceuticals Inc. (XENE) earnings per share in 2030 is 3.07, with individual estimates between 1.29 and 5.40.

How much revenue is Xenon Pharmaceuticals Inc. expected to make?

Analysts forecast Xenon Pharmaceuticals Inc. (XENE) revenue of $1.01B in 2030, based on 5 published estimates.

How many analysts cover XENE?

14 analysts contribute estimates for Xenon Pharmaceuticals Inc. (XENE). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.